Dual effect identified for arsenic in carcinogenesis
Arsenic seems to have a dual effect on carcinogenesis, according to a study recently published in Frontiers in Public Health.
Jun 20, 2022
0
2
Arsenic seems to have a dual effect on carcinogenesis, according to a study recently published in Frontiers in Public Health.
Jun 20, 2022
0
2
People with blood cancers living in rural areas are less likely to receive end-of-life hospice care compared to those living in metropolitan regions, according to a new study published today in Blood Advances.
Jun 15, 2022
0
2
A new chimeric antigen receptor (CAR) T-cell product had an acceptable safety profile and showed early signs of efficacy as a monotherapy and in combination with an mRNA vaccine in patients with solid tumors, according to ...
Apr 10, 2022
0
15
The Yo-Yo AD, an intermittent recovery test, can be used to assess the impact of a precision-based exercise intervention among children, adolescents, and young adults with hematologic malignancies, according to a study published ...
Mar 22, 2022
0
4
Inhibition of Ubiquitin Specific Peptidase 47 (USP47) was identified as a novel therapeutic target for hematologic malignancies bearing mutant oncoprotein EZH2, according to scientists from the Hefei Institutes of Physical ...
Jan 27, 2022
0
20
(HealthDay)—For patients with hematologic malignancies, septic shock is associated with high mortality rates and poor 90-day survival, according to a study published in the January issue of the Journal of the National Comprehensive ...
Jan 26, 2022
0
9
The first study to evaluate the clinical characteristics and outcomes of fully vaccinated patients with cancer who had breakthrough COVID-19 infections indicates they remained at high risk for hospitalization and death.
Dec 24, 2021
0
248
Mount Sinai and UC San Diego researchers have shown for the first time how mutations affecting a cellular process called RNA splicing alter cells to develop myelodysplastic syndrome (MDS) and other hematologic malignancies ...
Oct 7, 2021
0
21
(HealthDay)—There is a familial risk for hematologic malignancies, according to a study published online June 16 in Cancers.
Jul 7, 2021
0
1
(HealthDay)—Fifty-five percent of children, adolescents, and young adults with hematologic malignancies experience high-intensity end-of-life care (HI-EOLC), with an increased likelihood for those treated at medium or large ...
Jul 6, 2021
0
1